US Stock MarketDetailed Quotes

CATX Perspective Therapeutics

Watchlist
  • 3.0200
  • -0.0900-2.89%
Close Feb 14 16:00 ET
  • 3.0300
  • +0.0100+0.33%
Post 20:01 ET
204.11MMarket Cap-2.03P/E (TTM)

Perspective Therapeutics Key Stats

Perspective Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 151.330K--
--2024/Q4-- / 297.760K--
Nov 12, 20242024/Q3369.000K / 237.910K--
Aug 12, 20242024/Q2526.000K / 135.630K--
May 15, 20242024/Q1325.000K / 68.800K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 151.330K--
--2024/Q4-- / 297.760K--
Nov 12, 20242024/Q3369.000K / 237.910K--
Aug 12, 20242024/Q2526.000K / 135.630K--
May 15, 20242024/Q1325.000K / 68.800K--

Unlock Free Earnings Estimates

Perspective Therapeutics Earnings Reports

Read more

Trending Stocks

Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More